✓ Eligible clients and patients can apply pre-tax HSA or FSA funds

Extending Your
Results At Home

The weeks between appointments decide how much of your work is kept. The LYMA Laser delivers photobiomodulation at a therapeutic dose, at home, daily, without heat and without adding downtime.
LYMA Professional is open to physician practices, med spas, facialists, spas and clinics. How you work with us differs by practice type.

BECOME A PARTNER

✓ Eligible clients and patients can apply pre-tax HSA or FSA funds

Extending Your Results At Home

BECOME A PARTNER

Photobiomodulation, at a clinically meaningful dose

Near-infrared light absorbed by cytochrome c oxidase raises mitochondrial ATP output, which drives fibroblast proliferation and collagen synthesis. The mechanism is well described and has more than 60 years of clinical use behind it.

The constraint has always been dose at depth. Coherent, collimated light holds irradiance as it travels, which is what makes a therapeutic dose at dermal depth achievable in something a patient can hold.

LYMA Laser PRO:

Wavelength

808nm near-infrared

Source

3 x AlGaAs laser diodes

Irradiance

71 mW/cm²

Fluence per treatment area

4.3 J/cm²

Treatment time

180 seconds per treated area

Thermal effect

None. Athermic.

Regulatory

FDA cleared, 510(k) Class II. K243330

Laser classification

Class 3R

Photobiomodulation, at a clinically meaningful dose

Figures shown are for the LYMA Laser PRO, the model used in post-procedure protocol. Specifications for the LYMA Laser are available on request.

45 of 107 Genes Altered.
78% Mean Reduction In Wound Area

Gene expression in human skin following 808nm laser and LED exposure, with a companion clinical arm on wound healing.

Led by craniofacial and plastic surgeon Dr. Graeme Glass, published in Aesthetic Surgery Journal Open Forum, 2025.

READ THE PAPER

45 of 107 Genes Altered. 78% Mean Reduction In Wound Area

Gene expression in human skin following 808nm laser and LED exposure, with a companion clinical arm on wound healing. Led by craniofacial and plastic surgeon Dr. Graeme Glass, published in Aesthetic Surgery Journal Open Forum, 2025.

READ THE PAPER